U.S. Food and Drug Administration Approved 30% More Drugs in 2012

[Marketwired] – A sharp increase in drug approvals and mergers and acquisitions combined to create a bull market for the Biotechnology Industry in 2012. The iShares NASDAQ Biotechnology Index , the SPDR S&P Biotech ETF … more

View todays social media effects on NVGN

View the latest stocks trending across Twitter. Click to view dashboard

See who Novogen is hiring next, click here to view